You Searched For: THI+Total+Healthcare+Innovation+GmbH
11 362 results were found
Science Delivered
/cms/science-delivered
Science Delivered Science Delivered From scientific discovery to scale-up and commercial delivery Avantor® offers mission-critical products services and solutions on a global scale. Avantor powers innovation in virtually every stage of the most im...
Aurelia Gloves by Supermax Healthcare Inc
/cms/88119044CE2847AC9A0076953290F374
Aurelia Gloves by Supermax Healthcare Inc Supermax Healthcare is a leading international manufacturer distributor and marketer of high-quality medical gloves. Currently Supermax Healthcare exports to over 150 countries throughout the Americas Euro...
~~Avantor Services Success Story Biorepository Servi~~
/m-ca.vwr.com/fr_CA/images/Avantor_Services_Success_Story_Biorepository_Servi.pdf
CHALLENGE A top 25 biopharmaceutical company was using various external contract research organizations (CROs) to conduct GLP studies in order to support product development and new drug candidate submissions. After over 15 years of conducting the...
A Changing Landscape
/cms/webinar_changing_landscape_biopharma
A Changing Landscape for Biopharma Webinar On demand Replay The biopharma R&D landscape is rapidly expanding, and new sources of innovation are offering patients hope with each new breakthroughs. Novel platforms such as cell and gene therapies and...
A Changing Landscape for Biopharma
/cms/webinar_changing_landscape_biopharma
A Changing Landscape for Biopharma Webinar On demand Replay The biopharma R&D landscape is rapidly expanding and new sources of innovation are offering patients hope with each new breakthroughs. Novel platforms such as cell and gene therapies and ...
ls ge29064295 20131220222354
/m-pt.vwr.com/pt_PT/images/ls_ge29064295_20131220222354.pdf
imagination at work Application note 29-0642-95 AA Chromatography systems Depletion of albumin from serum samples using ÄKTA™ start Albumin comprises 55% to 65% of the total protein in serum. The abundance of this protein makes it difficult to stu...
ls ge29064295 20131220222354
/m-pl.vwr.com/pl_PL/images/ls_ge29064295_20131220222354.pdf
imagination at work Application note 29-0642-95 AA Chromatography systems Depletion of albumin from serum samples using ÄKTA™ start Albumin comprises 55% to 65% of the total protein in serum. The abundance of this protein makes it difficult to stu...
ls ge29064295 20131220222354
/m-be.vwr.com/nl_BE/images/ls_ge29064295_20131220222354.pdf
imagination at work Application note 29-0642-95 AA Chromatography systems Depletion of albumin from serum samples using ÄKTA™ start Albumin comprises 55% to 65% of the total protein in serum. The abundance of this protein makes it difficult to stu...
ls ge29064295 20131220222354
/m-no.vwr.com/no_NO/images/ls_ge29064295_20131220222354.pdf
imagination at work Application note 29-0642-95 AA Chromatography systems Depletion of albumin from serum samples using ÄKTA™ start Albumin comprises 55% to 65% of the total protein in serum. The abundance of this protein makes it difficult to stu...
~~Avantor Services Success Story Biorepository Servi~~
/m-us.vwr.com/en_US/images/Avantor_Services_Success_Story_Biorepository_Servi.pdf
CHALLENGE A top 25 biopharmaceutical company was using various external contract research organizations (CROs) to conduct GLP studies in order to support product development and new drug candidate submissions. After over 15 years of conducting the...
A Changing Landscape for Biopharma
/cms/webinar_changing_landscape_biopharma
A Changing Landscape for Biopharma Webinar On demand Replay The biopharma R&D landscape is rapidly expanding and new sources of innovation are offering patients hope with each new breakthroughs. Novel platforms such as cell and gene therapies and ...
~~ls ge29064295 20131220222354~~
/uk.vwr.com/en_GB/images/ls_ge29064295_20131220222354.pdf
imagination at work Application note 29-0642-95 AA Chromatography systems Depletion of albumin from serum samples using ÄKTA™ start Albumin comprises 55% to 65% of the total protein in serum. The abundance of this protein makes it difficult to stu...
~~29188433AA Production of recombinant monoclonal an~~
/m-nl.vwr.com/nl_NL/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-no.vwr.com/no_NO/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-pl.vwr.com/pl_PL/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-in.vwr.com/en_IN/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
65 - 80 of 11 362